Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)
Figure 4
Outcomes after10 years of PrEP rollout assuming no inadvertent PrEP uptake in previously infected individuals for optimistic, realistic and pessimistic scenarios, with four different strategies.
Panel A shows overall prevalence of HIV drug resistance and Panel B shows cumulative new HIV infections prevented.